In Papua New Guinea, 1500+ women die every year from childbirth-related causes – 80 times higher than in Australia. And these deaths are, mostly, preventable.
Your support will help stop preventable deaths of mothers and babies in PNG
One of the leading causes of mortality and morbidity globally, malaria was responsible for around 438,000 deaths and 214 million clinical cases in 2015. An estimated 3.2 billion people are at risk of the disease, with young children and pregnant women most affected.
A two-way pipeline will be created where our research discoveries can be tested in the field, and field programs inform discovery research through our long-standing connections with vulnerable target populations, especially in Papua New Guinea and Myanmar.
Through this program, Burnet will contribute to:
reaching the WHO elimination targets of a 90 percent reduction in malaria incidence and mortality through an active program of basic, discovery and translational research and in-field education, prevention and treatment programs.
supporting country programs in our region that assist WHO in reaching targets of elimination in at least 35 countries by 2030.
Deputy Director (People); Head of Malaria Research: Immunity, Vaccines and New Therapies Laboratory; Adjunct Professor Monash University
+61385062442
Antibody engineering to study responses mediating protective immunity
This project will involve engineering antibodies against malaria parasite proteins.
Clinical studies on malaria
The negative consequences of malaria and how to prevent them in children and pregnant women.
Developing new antimalarial drugs that block protein trafficking
Developing new antimalarial drugs that block protein trafficking and host cell modification.
Developing new tests for malaria elimination: G6PD deficiency
This project focuses on the development of new G6PD deficiency diagnostics.
Developing vaccines against malaria
This project aims to identify key antigens and specific epitopes that are targets of protective immunity.
Discovering the mechanisms and targets of immunity against malaria
Identifying the key targets of protective immunity in people who live in malaria-endemic regions.
Effectiveness of repellent on malaria incidence in SE Myanmar
A project to determine whether repellent delivered by volunteers will reduce malaria incidence.
FcgR Function in cellular responses to malaria parasites
Understanding how antibodies protect against malaria is crucial to vaccine development.
Functional antibody responses to malaria vaccine candidates
Understanding how functional immunity develops to potential malaria vaccine candidates.
HBMM: Home-based management of malaria in PNG
Making malaria diagnostics and treatments available at village-level in rural PNG.
Host red blood cell modification sustains the virulence of malaria parasites
Understanding how malaria parasites modify their human host cells to inform new antimalarials.
Immunity to malaria during pregnancy
How are pregnant women affected by infectious diseases such as malaria?
Immunity, drug efficacy and spread of antimalarial drug resistance
Identifying immune biomarkers to predict antimalarial efficacy is essential.
Major advances in understanding malaria immunity and biology
Identifying key targets of immunity, the mechanisms mediating immunity, and how it is acquired.
Mechanism of antimalarial drug action
Understanding how blood-stage replication of Plasmodium could be targeted by vaccines and novel drugs.
Optima decision science
Research and applications across disease areas to improve allocative efficiency.
Optima Malaria
Optima Malaria is a quantitative tool that assists with the allocation of budgets for malaria control programs.
Vaccines against Plasmodium vivax and P. falciparum malaria
This involves identifying and prioritising candidate antigens for vaccine development.
10 July, 2018
VIDEOS: Watch the key messages that emerged from the landmark 1st Malaria World Congress 2018 in Melbourne.
05 July, 2018
Congress founder Professor Brendan Crabb AC highlights call for change in MWC2018 keynote closing address.
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Disclaimer Privacy Policy Complaints Policy
Copyright © 2018 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
